Daner Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$396K Sell
1,906
-7
-0.4% -$1.55K 0.23% 52
2025
Q4
$426K Buy
+1,913
New +$436K 0.26% 49

Other funds holding ABBV

Daner Wealth Management's ABBV Position: Q1 2026 in Review

Daner Wealth Management reduced its AbbVie (ABBV) stake by 0.37% in Q1 2026, selling an estimated $1.55K and leaving 1,906 shares worth $396K. The position accounts for 0.23% of the portfolio, ranked #52.

Daner Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. The position peaked at $426K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Daner Wealth Management held 1,906 shares of AbbVie worth $396K as of Q1 2026.
  • Daner Wealth Management sold 7 AbbVie shares in Q1 2026, an estimated $1.55K.
  • AbbVie made up 0.23% of Daner Wealth Management's portfolio in Q1 2026, its #52 holding.
  • Daner Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
  • Daner Wealth Management's AbbVie position peaked at $426K in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Daner Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.